Search Results 1531-1540 of 16557 for oligomenorrhea

  1. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of tazemetostat in combination with R2 in subjects with Relapsed/Refractory Follicular ...

  2. Self-management of Sedative Therapy by Ventilated Patients - Mayo Clinic

    The purpose of this randomized clinical trial is to test the efficacy of dexmedetomidine for the self-management of sedative therapy (SMST) in a sample of ...

  3. Publications - Roger F. Shepherd, M.B., B.Ch. - Mayo Clinic

    Casanegra AI, Shepherd RF. Raynaud Phenomenon and Other Vasospastic Disorders. Cardiol Clin. 2021 Nov; 39 (4):583-599

  4. Patient Stories - Harini A. Chakkera, M.D., M.P.H. - Mayo Clinic

    Search for a doctor. Harini A. Chakkera, M.D., M.P.H.. Internist; Nephrologist. Request an Appointment · Overview · Publications. Patient Stories.

  5. Utilization of Sleep Pulse Oximetry in Fibromyalgia Patients - Mayo Clinic

    The purpose of this study is to evaluate the utilization of the sleep pulse oximeter test for fibromyalgia patients based on the Berlin and STOP-BANG survey ...

  6. Publications - Nilufer Taner, M.D., Ph.D. - Mayo Clinic

    Gliovascular transcriptional perturbations in Alzheimer's disease reveal molecular mechanisms of blood brain barrier dysfunction. Nat Commun. 2024 Jun 20; 15(1): ...

  7. Patient Stories - Sanford M. Fineman, M.D. - Mayo Clinic

    Sanford M. Fineman, M.D.. Neurologist. Request an Appointment · Overview · Publications ...

  8. MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01) - Mayo Clinic

    To determine the RP2D of MEN1611 when administered orally in combination with cetuximab to patients with PIK3CA mutated colorectal cancer failing irinotecan, ...

  9. Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - Mayo Clinic

    This is a multicenter, randomized (1:1; oral treprostinil to placebo), double-blind, placebo-controlled study in subjects with World Health Organization (WHO) ...

  10. Patient Stories - William K. Freeman, M.D. - Mayo Clinic

    3X your impact! ... Your gift can go 3X as far to shape the future of healthcare. Give Now.